Skip to search formSkip to main contentSkip to account menu

Dihydroergocryptine

Known as: Dihydroergocryptine [Chemical/Ingredient], Ergotaman-3',6',18-trione, 9,10alpha-dihydro-12'-hydroxy-5'alpha-isobutyl-2'-isopropyl 
A 9,10alpha-dihydro derivative of ERGOTAMINE that contains an isopropyl sidechain at the 2' position and an alpha-isobutyl sidechain at 5'alpha… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
To study the putative association of dopamine agonists with sleep attacks in patients with Parkinson's disease (PD) and their… 
Highly Cited
1990
Highly Cited
1990
Using a strategy based on nucleotide sequence homology between genes encoding receptors that interact with guanine nucleotide… 
Highly Cited
1986
Highly Cited
1986
[3H]Prazosin and [3H]WB4101 [2-(2,6-dimethoxyphenoxyethyl)aminomethyl-1,4 benzodioxane] have both been proposed to label alpha 1… 
Highly Cited
1985
Highly Cited
1985
In order to determine whether the high affinity state or the low affinity state of the dopamine receptor mediated the inhibition… 
Highly Cited
1978
Highly Cited
1978
Binding of [(3)H]dihydroergocryptine to platelet lysates appears to have all the characteristics of binding to alpha-adrenergic… 
Highly Cited
1978
Highly Cited
1978
Subcellular preparations of the anterior pituitary of rats and sheep bind [3H]dopamine ([3H]DA) and the dopaminergic agonist [3H…